Abstract

Review Article

Premature Ovarian Failure

Francesco Maria Bulletti, Maria Elisabetta Coccia, Maurizio Guido, Antonio Palagiano, Romualdo Sciorio, Evaldo Giacomucci and Carlo Bulletti*

Published: 15 July, 2025 | Volume 8 - Issue 3 | Pages: 061-068

Objective: To provide a rigorous, multidisciplinary synthesis of the epidemiological, genetic, immunological, and environmental factors contributing to Premature Ovarian Failure (POF), with particular attention to regional disparities, occupational exposures, the impact of chemotherapy, the occurrence and recurrence of endometrosis, and emerging fertility preservation strategies. 
Design: A structured literature review with an emphasis on recent advances in genetic and immunological understanding.
Setting: Academic research and clinical insights from multidisciplinary contributors.
Patients: Individuals diagnosed with POF as reported in the literature.
Interventions: Review of literature concerning epidemiology, genetic mutations, immunological disorders, and surgical outcomes linked to POF.
Main outcome measures: Identification of both established and emerging risk factors, validation of genetic and immunological markers, and clarification of diagnostic and preventive clinical approaches.
Results: The prevalence of POF varies globally, affecting 1% of women under 40. Genetic factors, particularly mutations in the FMR1 and BMP15 genes, play a significant role, alongside autoimmune diseases. Chemotherapy is a leading iatrogenic cause, while endometriosis and ovarian cyst surgeries significantly contribute to diminished ovarian reserve.
Conclusion: POF is a multifactorial condition with rising incidence in specific subgroups. Improved early detection, standardized biomarker use, and expanded access to fertility preservation are essential. Targeted genomic and occupational risk screening may enable personalized interventions. Further genomic studies are needed to elucidate rare mutations and their impact.

Read Full Article HTML DOI: 10.29328/journal.cjog.1001189 Cite this Article Read Full Article PDF

Keywords:

Premature ovarian failure; Epidemiology; Genetic causes; Chemotherapy; Immunological causes; Ovarian surgery

References

  1. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360(6):606–614. Available from: https://doi.org/10.1056/nejmcp0808697 org+9nejm.org+9europepmc.org+9
  2. Chapman C, Cree L, Shelling AN. The genetics of premature ovarian failure: current perspectives. Int J Womens Health. 2015;7:799–810. Available from: https://doi.org/10.2147/ijwh.s64024
  3. Coulam CB, Adamson SC. Premature ovarian failure: evidence for a genetic basis. Hum Reprod Update. 1996;2(6):482–490.
  4. Progetto Menopausa Italia Study Group. Premature ovarian failure: frequency and risk factors among women attending a network of menopause clinics in Italy. 2003;110(1):59–63. Available from: https://doi.org/10.1016/S1470-0328(02)02929-4
  5. Zhu X, Liu M, Dong R, Gao L, Hu J, Zhang X, et al. Mechanism exploration of environmental pollutants on premature ovarian insufficiency: a systematic review and meta-analysis. Reprod Sci. 2024;31:99–106. Available from: https://doi.org/10.1007/s43032-023-01326-5
  6. WHO. 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/infertility
  7. Zaake D, Amongin D, Beňová L, Kiwanuka SN, Nalwadda CK, et al. Prevalence, regional distribution, and determinants of infertility in Uganda between 2006 and 2016: analysis of three Demographic and Health Surveys. J Glob Health Rep. 2024;8:e2024008. Available from: https://doi.org/10.29392/001c.94212
  8. Rossetti R, Di Pasquale E, Marozzi A, Bione S, Toniolo D, Grammatico P, et al. BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein. Hum Mutat. 2009;30(5):804–810. Available from: https://doi.org/10.1002/humu.20961
  9. Nash Z, Davies M. Premature ovarian insufficiency. 2024;384. Available from: https://doi.org/10.1136/bmj-2023-077469
  10. Bakalov VK, Anasti JN, Calis KA, Vanderhoof VH, Premkumar A, Chen S, et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril. 2005;84(4):958–965. Available from: https://doi.org/10.1016/j.fertnstert.2005.04.060
  11. Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol. 2000;169(1–2):123–131. Available from: https://doi.org/10.1016/S0303-7207(00)00365-8 sagepub.com+8rep.bioscientifica.com+8journals.scholarsportal.info+8
  12. Somigliana E, Vercellini P, Pasinato L. Endometriosis and ovarian reserve: a dangerous association. 2003;23(2–3):187–192.
  13. Practice Committee of the American Society for Reproductive Medicine. Evidence‑based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline. Fertil Steril. 2021;116(1):36–47. Available from: https://doi.org/10.1016/j.fertnstert.2021.02.024
  14. Ter Welle-Butalid ME, Derhaag JG, van Bree BE, Vriens IJH, Goddijn M, Balkenende EME, et al. Outcomes of female fertility preservation with cryopreservation of oocytes or embryos in the Netherlands: a population‑based study. Hum Reprod. 2024;39(12):2693–2701. Available from: https://doi.org/10.1093/humrep/deae243
  15. Kasaven LS, Jones BP, Heath CR, Odia R, Green J, Petrie A, et al. Reproductive outcomes from ten years of elective oocyte cryopreservation. Arch Gynecol Obstet. 2022;306:1753–1760. Available from: https://doi.org/10.1007/s00404-022-06711-0
  16. Walker Z, Lanes A, Ginsburg E. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation. Reprod Biol Endocrinol. 2022;20:10. Available from: https://doi.org/10.1186/s12958-021-00884-0
  17. Milachich T, Shterev A. Are there optimal numbers of oocytes, spermatozoa, and embryos in assisted reproduction? JBRA Assist Reprod. 2016;20(3):142–149. Available from: https://doi.org/10.5935/1518-0557.20160032
  18. Sermondade N, Pasquier M, Ahdad‑Yata N, Fraison E, Grynberg M. Searching for the optimal number of oocytes to reach a live birth after in vitro fertilization: a systematic review with meta-analysis. F&S Rev. 2023;4(2):101–115. Available from: https://doi.org/10.1016/j.xfnr.2023.03.002
  19. Goldman RH, Racowsky C, Farland LV, Munné S, Ribustello L, Fox JH. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod. 2017;32(4):853–859. Available from: https://doi.org/10.1093/humrep/dex008
  20. Cascante SD, Berkeley AS, Licciardi F, McCaffrey C, Grifo JA. Planned oocyte cryopreservation: the state of the ART. Reprod Biomed Online. 2023;47(6):103367. Available from: https://doi.org/10.1016/j.rbmo.2023.103367
  21. Orvieto R. What is the expected live birth rate per thawed oocyte? Hum Reprod Update. 2024;30(5):648–649. Available from: https://doi.org/10.1093/humupd/dmae015

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Similar Articles

Recently Viewed

  • Anesthesia Considerations in Scoliosis Surgery - A Clinical Communication
    Anagha Warik and Abinav Sarvesh* Anagha Warik,Abinav Sarvesh*. Anesthesia Considerations in Scoliosis Surgery - A Clinical Communication. Int J Clin Anesth Res. 2025: doi: 10.29328/journal.ijcar.1001030; 9: 023-025
  • Validation of Prognostic Scores for Attempted Vaginal Delivery in Scar Uterus
    Mouiman Soukaina*, Mourran Oumaima, Etber Amina, Zeraidi Najia, Slaoui Aziz and Baydada Aziz Mouiman Soukaina*,Mourran Oumaima,Etber Amina,Zeraidi Najia,Slaoui Aziz,Baydada Aziz. Validation of Prognostic Scores for Attempted Vaginal Delivery in Scar Uterus. Clin J Obstet Gynecol. 2025: doi: 10.29328/journal.cjog.1001185; 8: 023-029
  • The Need of Wider and Deeper Skin Biopsy in Verrucous Carcinoma of the Sole
    Luca Damiani*, Giuseppe Argenziano, Andrea Ronchi, Francesca Pagliuca, Emma Carraturo, Vincenzo Piccolo and Gabriella Brancaccio Luca Damiani*,Giuseppe Argenziano,Andrea Ronchi,Francesca Pagliuca,Emma Carraturo,Vincenzo Piccolo,Gabriella Brancaccio. The Need of Wider and Deeper Skin Biopsy in Verrucous Carcinoma of the Sole. Ann Dermatol Res. 2025: doi: 10.29328/journal.adr.1001036; 9: 005-007
  • Epidemiologic aspects and risk factors associated with infertility in women undergoing assisted reproductive technology (ART) in north of Iran
    Marzieh Zamaniyan, Noushin Gordani*, Paniz Bagheri, Kaveh Jafari, Sepideh Peyvandi, Mojtaba Hajihoseini, Robabeh Taheripanah, Siavash Moradi, Salomeh Peyvandi and Arman Alborzi Marzieh Zamaniyan,Noushin Gordani*,Paniz Bagheri,Kaveh Jafari,Sepideh Peyvandi,Mojtaba Hajihoseini,Robabeh Taheripanah,Siavash Moradi,Salomeh Peyvandi,Arman Alborzi. Epidemiologic aspects and risk factors associated with infertility in women undergoing assisted reproductive technology (ART) in north of Iran. Clin J Obstet Gynecol. 2021: doi: 10.29328/journal.cjog.1001079; 4: 015-018
  • Superior Gluteal Artery Pseudoaneurysm following a Periacetabular Osteotomy
    Tess Szekelyi, Xavier Lannes, Mouas Jammal, Salah Dine Qanadli and Michael Wettstein* Tess Szekelyi, Xavier Lannes, Mouas Jammal, Salah Dine Qanadli, Michael Wettstein*. Superior Gluteal Artery Pseudoaneurysm following a Periacetabular Osteotomy. Arch Clin Exp Orthop. 2024: doi: 10.29328/journal.aceo.1001018; 8: 001-004

Read More

Most Viewed

Read More

Help ?